FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jan 17, 2020 at 12:52 PM.

  1. #1 cafead, Jan 17, 2020 at 12:52 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,057
    Likes Received:
    3
    via Yesterday the U.S. Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) met to discuss DURECT Corporation’s Posimir. The adcom had a 6-to-6 vote on whether to recommend approval of the drug.

    article source
     
    Quote

Reply to Thread